I5B-MC-JGDP - ClinicalTrials.gov - NCT03086369
I5B-MC-JGDP - ClinicalTrials.gov - NCT03086369
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have metastatic (Stage 4) pancreatic cancer diagnosis
Participant must have tumor tissue available or be willing to provide a biopsy
Participant must have discontinued all previous treatments for cancer at least 4 weeks prior
Participant must have a life expectancy of at least 3 months
Participants must NOT
Participant must not have had first line treatment for metastatic pancreatic cancer
Participant must not have participated in another clinical trial within the last 30 days - Female participant must not have a positive pregnancy test or be lactating
Trial Summary
Conditions the trial is for
Pancreatic Cancer
What the trial is testing?
Olaratumab, Nab-paclitaxel, Gemcitabine, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
186
Trial Dates
June 2017 - January 2022
Trial Phase
1
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have metastatic (Stage 4) pancreatic cancer diagnosis
Participant must have tumor tissue available or be willing to provide a biopsy
Participant must have discontinued all previous treatments for cancer at least 4 weeks prior
Participant must have a life expectancy of at least 3 months
Participants must NOT
Participant must not have had first line treatment for metastatic pancreatic cancer
Participant must not have participated in another clinical trial within the last 30 days - Female participant must not have a positive pregnancy test or be lactating
Trial Summary
Conditions the trial is for
Pancreatic Cancer
What the trial is testing?
Olaratumab, Nab-paclitaxel, Gemcitabine, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
186
Trial Dates
June 2017 - January 2022
Trial Phase
1
Trial Locations
Hide locations not currently recruiting